×
For best experience we recommend to activate Javascript in your browser.
CD31 antibody (APC)
The APC-conjugated Rat Monoclonal anti-CD31 antibody (Clone 390) (ABIN288792) specifically detects CD31 in FACS and IHC.
The antibody is reactive with Mouse samples.
Catalog No. ABIN288792
$1,594.53
$1,875.92
save $281.39 (-15 %)
Plus shipping costs $50.00
Delivery in 9 to 11 Business Days
Quick Overview for CD31 antibody (APC) (ABIN288792)
Target
See all CD31 (PECAM1) Antibodies
CD31 (PECAM1)
(Platelet/endothelial Cell Adhesion Molecule (PECAM1))
Reactivity
All reactivities for CD31 antibodies
Mouse
Host
All hosts for CD31 antibodies
Rat
Clonality
All clonalities for CD31 antibodies
Monoclonal
Conjugate
All conjugates for CD31 antibodies
This CD31 antibody is conjugated to APC
Application
All applications for CD31 antibodies
Flow Cytometry (FACS), Immunohistochemistry (IHC)
Clone
390
Product Details anti-CD31 Antibody (APC)
(hide)
Immunogen
CD31 antibody (Allophycocyanin) was raised in rat using murine leukocyte cell line 32 D as the immunogen.
Isotype
IgG2a
Alternatives
(show)
anti-Platelet/endothelial Cell Adhesion Molecule (PECAM1) (AA 681-738) antibody
PECAM1
Reactivity: Human, Mouse, Rat, Rabbit, Pig, Cow
FACS, WB, ELISA, IHC (p), IF (p), IF (cc)
Host: Rabbit
Polyclonal
unconjugated
Application Details
(hide)
Application Notes
Optimal conditions should be determined byt he investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
Lot specific
Buffer
Supplied as a liquid in PBS, with NaN3 added as preservative.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Handling Advice
Product is photosensitive and should be protected from light. Dilute only prior to immediate use.
Storage
4 °C
Target Details for CD31
(hide)
Target
CD31 (PECAM1)
(Platelet/endothelial Cell Adhesion Molecule (PECAM1))
Alternative Name
CD31
Pathways
Regulation of Actin Filament Polymerization
Recently viewed
(hide)
Chat with us , powered by LiveChat